Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wang, Wenmeng ^a,b   Luo, Junqing ^a   Xiang, Fang ^a   Liu, Xueting ^b   Jiang, Manli ^b   Liao, Lingjuan ^b   Hu, Jinyue ^b  

^a Department of Internal Medicine   (China)

^b CHANGSHA CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MESADP; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE DIPHOSPHATE; CISPLATIN; MRS 2211; NUCLEOLIN; PROTEIN BCL 2; PSB 0739; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; AZO COMPOUND; BCL2 PROTEIN, HUMAN; MESSENGER RNA; METHYLTHIO-ADP; NUCLEOTIDE; P2RY12 PROTEIN, HUMAN; P2RY13 PROTEIN, HUMAN; PHOSPHOPROTEIN; PURINERGIC P2 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL 5 PHOSPHATE; RNA BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN AORTIC ENDOTHELIAL CELL; HUMAN CELL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; AORTA; CELL LINE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONOCYTE; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANTINEOPLASTIC AGENTS; AORTA; APOPTOSIS; AZO COMPOUNDS; CELL LINE; CELL PROLIFERATION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MONOCYTES; PHOSPHOPROTEINS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; PURINERGIC AGONISTS; PURINERGIC ANTAGONISTS; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2Y1; RECEPTORS, PURINERGIC P2Y12; RNA, MESSENGER; RNA-BINDING PROTEINS; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION; THIONUCLEOTIDES;

EID: 84907718069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110101     Document Type: Article

References (57)

1. Ginisty H, Sicard H, Roger B, Bouvet P (1999) Structure and functions of nucleolin. J Cell Sci 112: 761-772.
2. Mongelard F, Bouvet P (2007) Nucleolin: a multiFACeTed protein. Trends Cell Biol 17: 80-86.
3. Bouvet P, Allain FH, Finger LD, Dieckmann T, Feigon J (2001) Recognition of pre-formed and flexible elements of an RNA stem-loop by nucleolin. J Mol Biol 309: 763-775.
4. Ugrinova I, Monier K, Ivaldi C, Thiry M, Storck S, et al. (2007) Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol Biol 8: 66.
5. Angelov D, Bondarenko VA, Almagro S, Menoni H, Mongelard F, et al. (2006) Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes. Embo J 25: 1669-1679.
6. Hovanessian AG, Soundaramourty C, El Khoury D, Nondier I, Svab J, et al. (2010) Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization. PLoS One 5: e15787.
7. Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, et al. (2009) Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol 76: 984-991.
8. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, et al. (2008) Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 3: e2518.
9. Fogal V, Sugahara KN, Ruoslahti E, Christian S (2009) Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 12: 91-100.
10. Watanabe T, Hirano K, Takahashi A, Yamaguchi K, Beppu M, et al. (2010) Nucleolin on the cell surface as a new molecular target for gastric cancer treatment. Biol Pharm Bull 33: 796-803.
11. Zhuo W, Luo C, Wang X, Song X, Fu Y, et al. (2010)Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells. J Pathol 222: 249-260.
12. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, et al. (2011) Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med.
13. Cancio-Lonches C, Yocupicio-Monroy M, Sandoval-Jaime C, Galvan-Mendoza I, Urena L, et al. (2011) Nucleolin interacts with the feline calicivirus 3' untranslated region and the protease-polymerase NS6 and NS7 proteins, playing a role in virus replication. J Virol 85: 8056-8068.
14. Strang BL, Boulant S, Coen DM (2010) Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J Virol 84: 1771-1784.
15. Sagou K, Uema M, Kawaguchi Y (2010) Nucleolin is required for efficient nuclear egress of herpes simplex virus type 1 nucleocapsids. J Virol 84: 2110-2121.
16. Ishimaru D, Zuraw L, Ramalingam S, Sengupta TK, Bandyopadhyay S, et al. (2010) Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1). J Biol Chem 285: 27182-27191.
17. Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM (2010) Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res 38: 4807-4820.
18. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, et al. (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
19. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, et al. (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97: 587-600.
20. Rong W, Gourine AV, Cockayne DA, Xiang Z, Ford AP, et al. (2003) Pivotal role of nucleotide P262 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia. J Neurosci 23: 11315-11321.
21. Jin J, Quinton TM, Zhang J, Rittenhouse SE, Kunapuli SP (2002) Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood 99: 193-198.
22. Gachet C, Hechler B, Leon C, Vial C, Leray C, et al. (1997) Activation of ADP receptors and platelet function. Thromb Haemost 78: 271-275.
23. Murugappa S, Kunapuli SP (2006) The role of ADP receptors in platelet function. Front Biosci 11: 1977-1986.
24. Amisten S, Meidute-Abaraviciene S, Tan C, Olde B, Lundquist I, et al. (2010) ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 53: 1927-1934.
25. Jacquet S, Malaval C, Martinez LO, Sak K, Rolland C, et al. (2005) The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci 62: 2508-2515.
26. Battista AG, Ricatti MJ, Pafundo DE, Gautier MA, Faillace MP (2009) Extracellular ADP regulates lesion-induced in vivo cell proliferation and death in the zebrafish retina. J Neurochem 111: 600-613.
27. Nasu-Tada K, Koizumi S, Inoue K (2005) Involvement of beta1 integrin in microglial chemotaxis and proliferation on fibronectin: different regulations by ADP through PKA. Glia 52: 98-107.
28. Schafer R, Hartig R, Sedehizade F, Welte T, Reiser G (2006) Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways. Febs J 273: 3756-3767.
29. Wang DJ, Huang NN, Heppel LA (1992) Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153: 221-233.
30. Lyubchenko T, Woodward H, Veo KD, Burns N, Nijmeh H, et al. (2011) P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Cell Physiol 300: C266-275.
31. Sellers LA, Simon J, Lundahl TS, Cousens DJ, Humphrey PP, et al. (2001) Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogenactivated protein kinases and induce apoptosis. J Biol Chem 276: 16379-16390.
32. Tan C, Salehi A, Svensson S, Olde B, Erlinge D (2010) ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells. Cell Mol Life Sci 67: 445-453.
33. Vitolo OV, Ciotti MT, Galli C, Borsello T, Calissano P (1998) Adenosine and ADP prevent apoptosis in cultured rat cerebellar granule cells. Brain Res 809: 297-301.
34. von Albertini M, Palmetshofer A, Kaczmarek E, Koziak K, Stroka D, et al. (1998) Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun 248: 822-829.
35. Shen J, DiCorleto PE (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 102: 448-456.
36. De Simone R, Niturad CE, De Nuccio C, Ajmone-Cat MA, Visentin S, et al. (2010) TGF-beta and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. J Neurochem 115: 450-459.
37. Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, et al. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9: 1512-1519.
38. Wang L, Olivecrona G, Gotberg M, Olsson ML, Winzell MS, et al. (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 96: 189-196.
39. Ben Addi A, Cammarata D, Conley PB, Boeynaems JM, Robaye B (2010) Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 185: 5900-5906.
40. Lv Q, Yang M, Liu X, Zhou L, Xiao Z, et al. (2012) MDP up-regulates the gene expression of type I interferons in human aortic endothelial cells. Molecules 17: 3599-3608.
41. Sun R, Zhang Y, Lv Q, Liu B, Jin M, et al. (2011) Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 286: 15918-15928.
42. Song Q, Wang G, Chu Y, Zhou L, Jiang M, et al. (2013) TNF-a up-regulates cellular inhibitor of apoptosis protein 2 (c-IAP2) via c-Jun N-terminal kinase (JNK) pathway in nasopharyngeal carcinoma. Int Immunopharmacol 16: 148-153.
43. Zhang Y, Sun R, Liu B, Deng M, Zhang W, et al. (2009) TLR3 activation inhibits nasopharyngeal carcinoma metastasis via downregulation of chemokine receptor CXCR4. Cancer Biol Ther 8: 1826-1830.
44. Bates PJ, Kahlon JB, Thomas SD, Trent JO, Miller DM (1999) Antiproliferative activity of G-rich oligonucleotides correlates with protein binding. J Biol Chem 274: 26369-26377.
45. Xu X, Hamhouyia F, Thomas SD, Burke TJ, Girvan AC, et al. (2001) Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem 276: 43221-43230.
46. Lee YH, Mungunsukh O, Tutino RL, Marquez AP, Day RM (2010) Angiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells. J Cell Sci 123: 1634-1643.
47. Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, et al. (2003) Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem 278: 8572-8579.
48. Kudirka JC, Panupinthu N, Tesseyman MA, Dixon SJ, Bernier SM (2007) P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix: involvement of beta3 integrins. J Cell Physiol 213: 54-64.
49. Czajkowski R, Banachewicz W, Ilnytska O, Drobot LB, Baranska J (2004) Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serumdeprived and nonstarved glioma C6 cells. Br J Pharmacol 141: 497-507.
50. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK (2004) Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem 279: 10855-10863.
51. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ (2008) The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 68: 2358-2365.
52. Otake Y, Sengupta TK, Bandyopadhyay S, Spicer EK, Fernandes DJ (2005) Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin downregulation and destabilization of Bcl-2 mRNA. Mol Pharmacol 67: 319-326.
53. Shen J, DiCorleto PE (2008) ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res 102: 448-456.
54. De Simone R, Niturad CE, De Nuccio C, Ajmone-Cat MA, Visentin S, et al. (2010) TGF-b and LPS modulate ADP-induced migration of microglial cells through P2Y1 and P2Y12 receptor expression. J Neurochem 115: 450-459.
55. Schwartz TR, Vasta CA, Bauer TL, Parekh-Olmedo H, Kmiec EB (2008) Grich oligonucleotides alter cell cycle progression and induce apoptosis specifically in OE19 esophageal tumor cells. Oligonucleotides 18: 51-63.
56. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, et al. (2007) Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 109: 3069-3075.
57. Maaser K, Hopfner M, Kap H, Sutter AP, Barthel B, et al. (2002) Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br J Cancer 86: 636-644.